These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 16797905)
21. Interleukin-10-592C/A, -819C/T and -1082A/G promoter variants affect the susceptibility to nephropathy in Tunisian type 2 diabetes (T2DM) patients. Ezzidi I; Mtiraoui N; Kacem M; Mallat SG; Mohamed MB; Chaieb M; Mahjoub T; Almawi WY Clin Endocrinol (Oxf); 2009 Mar; 70(3):401-7. PubMed ID: 18616700 [TBL] [Abstract][Full Text] [Related]
22. Interleukin-6 receptor gene polymorphism modulates interleukin-6 levels and the metabolic syndrome: GBCS-CVD. Jiang CQ; Lam TH; Liu B; Lin JM; Yue XJ; Jin YL; Cheung BM; Thomas GN Obesity (Silver Spring); 2010 Oct; 18(10):1969-74. PubMed ID: 20186139 [TBL] [Abstract][Full Text] [Related]
23. Measures of obesity and metabolic syndrome in Indian Americans in northern California. Misra KB; Endemann SW; Ayer M Ethn Dis; 2006; 16(2):331-7. PubMed ID: 17682232 [TBL] [Abstract][Full Text] [Related]
24. Gene variants of monocyte chemoattractant protein 1 and components of metabolic syndrome in KORA S4, Augsburg. Sedlmeier EM; Grallert H; Huth C; Löwel H; Herder C; Strassburger K; Giani G; Wichmann HE; Hauner H; Illig T; Rathmann W Eur J Endocrinol; 2007 Mar; 156(3):377-85. PubMed ID: 17322498 [TBL] [Abstract][Full Text] [Related]
26. The -786C/T single-nucleotide polymorphism in the promoter of the gene for endothelial nitric oxide synthase: insensitivity to physiologic stimuli as a risk factor for rheumatoid arthritis. Melchers I; Blaschke S; Hecker M; Cattaruzza M Arthritis Rheum; 2006 Oct; 54(10):3144-51. PubMed ID: 17009241 [TBL] [Abstract][Full Text] [Related]
27. Association between C-589T polymorphisms of interleukin-4 gene promoter and asthma: a meta-analysis. Li Y; Guo B; Zhang L; Han J; Wu B; Xiong H Respir Med; 2008 Jul; 102(7):984-92. PubMed ID: 18396027 [TBL] [Abstract][Full Text] [Related]
28. Variants of the transcription factor 7-like 2 gene (TCF7L2) are strongly associated with type 2 diabetes but not with the metabolic syndrome in the MONICA/KORA surveys. Marzi C; Huth C; Kolz M; Grallert H; Meisinger C; Wichmann HE; Rathmann W; Herder C; Illig T Horm Metab Res; 2007 Jan; 39(1):46-52. PubMed ID: 17226113 [TBL] [Abstract][Full Text] [Related]
29. Association of hypertension with single nucleotide polymorphisms in the quantitative trait locus for abdominal obesity-metabolic syndrome on chromosome 17. Cheung BM; Leung RY; Man YB; Ong KL; Wong LY; Lau CP; Lam KS J Hum Hypertens; 2006 Jun; 20(6):419-25. PubMed ID: 16511504 [TBL] [Abstract][Full Text] [Related]
30. Association between the Gln223Arg polymorphism of the leptin receptor and metabolic syndrome in free-living community elderly. Gottlieb MG; Bodanese LC; Leite LE; Schwanke CH; Piccoli Jda C; da Rocha MI; da Cruz IB Metab Syndr Relat Disord; 2009 Aug; 7(4):341-8. PubMed ID: 19344216 [TBL] [Abstract][Full Text] [Related]
31. IL6 and IL1B polymorphisms are associated with fat mass in older men: the MrOS Study Sweden. Strandberg L; Mellström D; Ljunggren O; Grundberg E; Karlsson MK; Holmberg AH; Orwoll ES; Eriksson AL; Svedberg J; Bengtsson M; Ohlsson C; Jansson JO Obesity (Silver Spring); 2008 Mar; 16(3):710-3. PubMed ID: 18239554 [TBL] [Abstract][Full Text] [Related]
32. Increase in interleukin-6 following arterial injury is related to insulin resistance, the -174G-->C polymorphism and complex plaque morphology. Marso SP; House JA; Hopkins PJ Int J Immunogenet; 2006 Oct; 33(5):347-54. PubMed ID: 16984279 [TBL] [Abstract][Full Text] [Related]
33. Polymorphisms of the interleukin-6 gene promoter and abdominal aortic aneurysm. Smallwood L; Allcock R; van Bockxmeer F; Warrington N; Palmer LJ; Iacopetta B; Norman PE Eur J Vasc Endovasc Surg; 2008 Jan; 35(1):31-6. PubMed ID: 17996468 [TBL] [Abstract][Full Text] [Related]
34. Impact of interleukin 6 -174G>C polymorphism on obesity-related metabolic disorders in people with excess in body weight. Goyenechea E; Parra D; Martínez JA Metabolism; 2007 Dec; 56(12):1643-8. PubMed ID: 17998015 [TBL] [Abstract][Full Text] [Related]
35. Interleukin-18 promoter polymorphisms in patients with Behçet's disease. Lee YJ; Kang SW; Park JJ; Bae YD; Lee EY; Lee EB; Song YW Hum Immunol; 2006 Oct; 67(10):812-8. PubMed ID: 17055358 [TBL] [Abstract][Full Text] [Related]
36. Interleukin-18 gene promoter polymorphisms in women with gestational trophoblastic diseases. Kashef MA; Dehaghani AS; Naeimi S; Fattahi MJ; Ghaderi A J Reprod Med; 2008 Nov; 53(11):853-9. PubMed ID: 19097518 [TBL] [Abstract][Full Text] [Related]
37. Interleukin-10 promoter polymorphisms in patients with systemic lupus erythematosus from the Canary Islands. Rosado S; Rua-Figueroa I; Vargas JA; Garcia-Laorden MI; Losada-Fernandez I; Martin-Donaire T; Perez-Chacon G; Rodriguez-Gallego C; Naranjo-Hernandez A; Ojeda-Bruno S; Citores MJ; Perez-Aciego P Int J Immunogenet; 2008 Jun; 35(3):235-42. PubMed ID: 18397303 [TBL] [Abstract][Full Text] [Related]
38. Association between two common polymorphisms of PPARgamma gene and metabolic syndrome families in a Chinese population. Yang LL; Hua Q; Liu RK; Yang Z Arch Med Res; 2009 Feb; 40(2):89-96. PubMed ID: 19237017 [TBL] [Abstract][Full Text] [Related]
39. Influence of interleukin 10 promoter polymorphisms in susceptibility to giant cell arteritis in Northwestern Spain. Rueda B; Roibas B; Martin J; Gonzalez-Gay MA J Rheumatol; 2007 Jul; 34(7):1535-9. PubMed ID: 17552041 [TBL] [Abstract][Full Text] [Related]